Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

ADVANCED INSTRUMENTS

Advanced Instruments designs, manufactures and markets laboratory products for the clinical, food and dairy, microbio... read more Featured Products: More products

Download Mobile App




Advanced Instruments Appoints New CEO

By LabMedica International staff writers
Posted on 17 May 2017
Advanced Instruments, LLC, which designs, manufactures, and markets instrumentation and associated consumables for clinical, pharmaceutical, biotechnology, microbiology and dairy laboratories, has announced the appointment of Byron Selman as Chief Executive Officer. More...
Mr. Selman replaces John Coughlin, who served as CEO of Advanced Instruments for over 16 years, and will continue in his retirement as a non-executive Member of the Board.

Mr. Selman brings with him a broad range of experience across multiple functional disciplines including sales, marketing, business development, engineering, operations, and general management. He joins Advanced Instruments after serving as President of Global Markets with Haemonetics Corporation, prior to which he spent over 20 years with Pall Corporation in various executive level and general management positions. Selman holds a Bachelor of Science degree in Mechanical Engineering from Case Western Reserve University, and a Master of Business Administration degree from the Frank G. Zarb School of Business at Hofstra University.

“We are excited to have Byron join Advanced Instruments,” said Craig Majernik, Managing Director at Windjammer Capital Investors, which acquired the company in October 2016. “His proven leadership abilities and demonstrated record of success position him well to lead the execution of the company’s organic and acquisition growth strategy.”

Selman said, “Advanced Instruments represents a unique opportunity, given its well-respected brand, technical know-how, and channels to market. I am encouraged by the multiple avenues available to the company to enhance and expand its well-established platform in the clinical diagnostic and biopharmaceutical tools markets.”


Gold Member
Hematology Analyzer
Medonic M32B
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Urine Chemistry Control
Dropper Urine Chemistry Control
Gold Member
Immunochromatographic Assay
CRYPTO Cassette
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Immunology

view channel
Image: Whole-genome sequencing enables broader detection of DNA repair defects to guide PARP inhibitor cancer therapy (Photo courtesy of Illumina)

Whole-Genome Sequencing Approach Identifies Cancer Patients Benefitting From PARP-Inhibitor Treatment

Targeted cancer therapies such as PARP inhibitors can be highly effective, but only for patients whose tumors carry specific DNA repair defects. Identifying these patients accurately remains challenging,... Read more

Pathology

view channel
Image: AI models combined with DOCI can classify thyroid cancer subtypes (Photo courtesy of T. Vasse et al., doi 10.1117/1.BIOS.3.1.015001)

AI-Powered Label-Free Optical Imaging Accurately Identifies Thyroid Cancer During Surgery

Thyroid cancer is the most common endocrine cancer, and its rising detection rates have increased the number of patients undergoing surgery. During tumor removal, surgeons often face uncertainty in distinguishing... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.